Organic Active Ingredients TRIZ Cases

Dual inhibition of BCR-ABL and MEK pathways synergistically eliminates resistant CML stem cells while sparing normal hematopoietic cells.

Segmented crystalline forms of the hexafluoropropanyl ester MAGL inhibitor resolve selectivity issues over FAAH.

Non-ionic contrast agents resolve the trade-off between visibility during administration and drug loading capacity in hydrophilic polymer microspheres.

Silicon dioxide layers enable low-temperature bonding of titanium and silicon pump parts, preventing corrosion in implantable drug delivery systems.

Amylase enzymes cleave glycosidic bonds in polysaccharides to remove necrotic tissue without triggering allergic reactions or auto-digestion.

Optimized chitosan pH and ionic strength enable solubility at physiological levels while maintaining clot stability when combined with PRP.

Specific compounds of formula I inhibit Bruton's tyrosine kinase to reduce autoantibody production and inflammation in rheumatoid arthritis treatments.

Combining nicotinamide riboside with iron addresses mitochondrial dysfunction and iron deficiency, improving heart function and extending lifespan.

Heterocyclic compounds resist IL-6-induced STAT3 phosphorylation, resolving insufficient potency of existing inhibitors.

On-chip microdialysis establishes a transmembrane gradient for active drug loading, reducing polydispersity.

New amide compounds reduce cholesterol and triglycerides while preventing gallstones, offering a safer alternative to statins with lower hepatotoxicity.

Modified Hoffmann reaction with bis(trifluoroacetoxyiodo)benzene synthesizes substantially pure (-) huperzine A, overcoming low natural extraction yields.

5-HT2C receptor agonists reduce food intake to manage weight gain during smoking cessation.

A porous polymeric device recruits and activates dendritic cells using embedded TLR agonists.

Naproxen ammonium gel improves skin permeation, resolving inconsistent pain relief from conventional NSAID formulations.

Pyridine and pyrimidine derivatives inhibit CDK9 to induce apoptosis in tumor cells, addressing the lack of effective inhibitors for hematological malignancies.

A petrolatum-based polyhexamethylene biguanide composition penetrates the nail plate to deliver antifungal agents directly to the infection site.

Splice-switching oligonucleotides modulate pre-mRNA splicing to reduce AR and EGFR expression.

Film forming excipient creates protective layer preventing secondary exposure while maintaining absorption.

Oral venglustat formulations overcome blood-brain barrier limitations to treat neurological symptoms in Gaucher disease patients.

Delayed aspirin release alongside fumaric acid boosts bioavailability, reducing cutaneous flush side effects.

A four-step synthetic process produces the target imidazopyridine amine using displacement and cyclization reactions.

A composition of glutamine, curcumin extract, and Lactobacillus rhamnosus regulates anxiety symptoms.

A nicotine pouch filler uses cellulose or sugar alcohol excipients to regulate active substance elution kinetics.

Substituted pyrazinyl-phenyl ureas inhibit Chk-1 kinase, sensitizing cancer cells to chemotherapy and radiation therapy.

Detecting KRAS gene mutations identifies colorectal cancer patients likely to respond to TAS-102 chemotherapy.

Granulation with inert atmosphere and localized excipients stabilizes tetrahydrofolic acid while maintaining fast estrogen release.

Substituted pyrrolobenzodiazepines resolve toxicity and efficacy trade-offs by optimizing structural parameters for broad-spectrum antifungal activity.

A prefilled syringe kit delivers hazardous agents via autoinjector for consistent subcutaneous dosing.

Isoprenyl compounds modulate G-protein signaling cascades to reduce inflammation without the side effects of traditional corticosteroids.

Combines levamisole with macrocyclic lactones to extend treatment intervals and reduce drench resistance in ruminants.

Indole analogs block bromodomain activity to attenuate transcription, promoting oligodendrocyte differentiation and neural repair in neurological disorders.

Hybrid RNA-DNA aptamers resist serum degradation while directing therapeutic payloads to transferrin receptors, reducing toxicity in normal cells.

Modifying pyridoindolone structures resolves the contradiction between anticancer efficacy and specificity while enabling dual therapeutic potential.

Chiral resolution separates the active (+)-trans enantiomer from harmful (-)-trans isomers, eliminating adverse side effects in cancer therapy.

Novel Smac peptidomimetic intermediates bind the BIR3 domain of Inhibitor of Apoptosis Proteins to displace endogenous Smac.

Administering GCPII inhibitors reduces muscle wasting by blocking glutamate carboxypeptidase II, slowing sarcopenia progression.

Substituted pyrazole compounds modulate cytokine production and B cell activity to treat inflammatory diseases while reducing toxicity.

A small molecule compound of formula I inhibits neuroinflammatory responses and synaptic phagocytosis in microglial cells.

Sensitizing agents induce macropinocytosis to boost siRNA uptake, overcoming tight junction barriers that limit gene silencing efficacy.

A hydrophobic matrix and coating isolate an opioid antagonist within extruded particles, blocking abuse while preserving analgesic efficacy.

Combines PARP inhibitors with Treg or macrophage agents to overcome insufficient immune response in BRCA-deficient cancers.

A p38 MAP kinase inhibitor attenuates inflammatory responses in severe influenza by blocking pro-inflammatory mediator release from endothelial cells.

Formula 1 compounds inhibit ERK2 activity to reduce tumor growth across melanoma and pancreatic cancers.

Weak acid buffering maintains pH stability to prevent calcium fluoride precipitation and improve formulation reliability.